Biotech - Technical Analysis Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotech - Technical Analysis

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Jibacoa who wrote (528)	8/23/2002 2:58:57 PM
From: Jibacoa	of 544

ELN Is up another 13.51% on volume 3x its daily average. (It has continued the uptrend that started in the afternoon on Aug.21) Today it said that it has given WPI an exclusive U.S. marketing rights to nifedipine, the generic version of BAY's Adalat and PFE's Procardia. (ELN has weakened some in the last half hour after encountering some resistance at the $3.43 level.<g>) It seems the new CEO (Garo Armen) is restoring investors confidence.<g> siliconinvestor.com siliconinvestor.com Bernard

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next